Drugmakers are closing out a year when they achieved several historic firsts , including weight loss drug, that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry's newest gold rush 2023, as demand for costly but highly effective treatments from Novo Nordisk and Eli Lilly surged. Patients and investors also saw that the benefits of the medicines could extend beyond their original purposes.
If characterizing the current state of EV market, it is going from optimistic to realistic. You can see waning demand, growth is still there, but it is not growing at the rate which everybody expected. After years of EV euphoria, the EV industry is cooling off now, some automakers are scaling back or delaying their electric vehicle plans. Also the outlook for the EV industry is facing more uncertainty and seeing some warning signs.
Federal Reserve Governor Christopher Waller recently acknowledged that interest rate cuts are likely this year, but the central bank can take its time relaxing monetary policy.
Higher interest rates, a potential recession and persistently high prices made consumers substantially less confident about the current state of the economy as well as where things are heading.There are factors, however, that have cast doubt on the Fed’s credibility.
What’s happening in resent weeks has been confusing the market. Fueled by the Fed’s pivot in policy, the markets climbed the wall of worry and set new highs; Then the Fed’s minute dampened the market enthusiasm, resulting in seven straight sessions sell-off. After several days digestion, the rally is back on its track. So where are the markets headed for after new highs? Will the Fed fall into a rut in terms of monetary policy? What are the consequences of that?
